In addition, CEBPB is highly expressed in glioblastoma stem cells and has been shown to promote glioma progression by regulating cyclin D1 and inducing distinct resistance to chemotherapy [37, 38]. The gene discussed is CEBPB; the disease is central nervous system cancer.